Alerts will be sent to your verified email
Verify Email
WINDLAS
|
Windlas Biotech
|
SMS Pharmaceuticals
|
Amrutanjan Healthcar
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
10.64 % | 9.06 % | 14.67 % |
|
5yr Avg Net Profit Margin
|
7.49 % | 7.28 % | 8.57 % |
|
Price to Book
|
4.16 | 3.3 | 6.38 |
|
P/E
|
32.27 | 28.83 | 38.2 |
|
5yr Avg Cash Conversion Cycle
|
-12.87 Days | 93.25 Days | 21.59 Days |
|
5yr Average Interest Coverage Ratio
|
42.87 | 4.77 | 27.21 |
|
5yr Avg ROCE
|
16.39 % | 12.12 % | 24.07 % |
|
5yr Avg Operating Profit Margin
|
12.11 % | 17.98 % | 14.15 % |
|
5 yr average Debt to Equity
|
0.05 | 0.53 | 0.12 |
|
5yr CAGR Net Profit
|
30.97 % | 9.56 % | 16.38 % |
|
5yr Average Return on Assets
|
7.71 % | 4.75 % | 10.59 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
62.34 % | 66.26 % | 46.52 % |
|
Share Pledged by Promoters
|
0.0 | 32.49 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
2.39 % | 2.09 % | -3.5 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-5.1 % | 3.03 % | 1.61 % |
|
Windlas Biotech
|
SMS Pharmaceuticals
|
Amrutanjan Healthcar
|
|---|